Arcturus Therapeutics reports Q4 and full-year 2025 financial results

seekingalpha.com

Arcturus Therapeutics reported its Q4 and full-year 2025 financial results on March 3, 2026. The company's leadership, including CEO Joe Payne and Chief Medical Officer Dr. Alan Cohen, discussed financial updates and pipeline progress during the earnings call. Key personnel from various financial institutions attended the call to discuss the company's performance and outlook.


With a significance score of 0.9, this news ranks in the top 78% of today's 28064 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Arcturus Therapeutics reports Q4 and full-year 2025 financial results | News Minimalist